Evidence map›Paper›PMID 26921955›Full record

ArticleMethods in enzymology2016

Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.

Christoph Seibert, Anthony Sanfiz, Thomas P Sakmar, Christopher T Veldkamp

Abstract read
In one paragraph

Article in Methods in enzymology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. CCR7 Sulfotyrosine Enhances CCL21 Binding.International journal of molecular sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christoph SeibertLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, USA.
Anthony SanfizLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, USA.
Thomas P SakmarLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, USA.
Christopher T VeldkampDepartment of Chemistry, University of Wisconsin-Whitewater, Whitewater, Wisconsin, USA. Electronic address: veldkamc@uww.edu.
Rockefeller University · USUniversity of Wisconsin–Whitewater · US

Funding

Structural studies of chemokines that target metastatic cancer cells to the lymphR15CA159202 · NCI · UNIVERSITY OF WISCONSIN WHITEWATER · PI VELDKAMP, CHRISTOPHER T · 2011 to 2011
$335k
NCI NIH HHS 1R15CA159202-01NCI NIH HHS R15 CA159202
6 · The paper itself

Abstract

In most chemokine receptors, one or multiple tyrosine residues have been identified within the receptor N-terminal domain that are, at least partially, modified by posttranslational tyrosine sulfation. For example, tyrosine sulfation has been demonstrated for Tyr-3, -10, -14, and -15 of CCR5, for Tyr-3, -14, and -15 of CCR8, and for Tyr-7, -12, and -21 of CXCR4. While there is evidence for several chemokine receptors that tyrosine sulfation is required for optimal interaction with the chemokine ligands, the precise role of tyrosine sulfation for chemokine receptor function remains unclear. Furthermore, the function of the chemokine receptor N-terminal domain in chemokine binding and receptor activation is also not well understood. Sulfotyrosine peptides corresponding to the chemokine receptor N-termini are valuable tools to address these important questions both in structural and functional studies. However, due to the lability of the sulfotyrosine modification, these peptides are difficult to obtain using standard peptide chemistry methods. In this chapter, we provide methods to prepare sulfotyrosine peptides by enzymatic in vitro sulfation of peptides using purified recombinant tyrosylprotein sulfotransferase (TPST) enzymes. In addition, we also discuss alternative approaches for the generation of sulfotyrosine peptides and methods for sulfopeptide analysis.

Indexed as

AnimalsEscherichia coliHumansMagnetic Resonance SpectroscopyMammalsMass SpectrometryProtein EngineeringProtein RefoldingReceptors, ChemokineRecombinant ProteinsSulfotransferasesTyrosineprotein-tyrosine sulfotransferaseReceptors, ChemokineRecombinant ProteinsSulfotransferasesTyrosinetyrosine O-sulfateBiased agonismChemokine receptorsChemokinesGPCRLigand biasPeptide sulfationPosttranslational modificationSulfopeptideSulfotyrosineSulfotyrosine peptideTPSTTyrosine sulfationTyrosylprotein sulfotransferase

Identifiers

PMID26921955
PMCPMC4817839
OpenAlexW2210221948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.